382 related articles for article (PubMed ID: 18499628)
1. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1.
Marincsák R; Tóth BI; Czifra G; Szabó T; Kovács L; Bíró T
Anesth Analg; 2008 Jun; 106(6):1890-6. PubMed ID: 18499628
[TBL] [Abstract][Full Text] [Related]
2. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line.
Szoke E; Börzsei R; Tóth DM; Lengl O; Helyes Z; Sándor Z; Szolcsányi J
Eur J Pharmacol; 2010 Feb; 628(1-3):67-74. PubMed ID: 19958765
[TBL] [Abstract][Full Text] [Related]
3. Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors.
McHugh D; McMaster RS; Pertwee RG; Roy S; Mahadevan A; Razdan RK; Ross RA
J Pharmacol Exp Ther; 2006 Feb; 316(2):955-65. PubMed ID: 16207832
[TBL] [Abstract][Full Text] [Related]
4. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
[TBL] [Abstract][Full Text] [Related]
5. Tramadol and its metabolite m1 selectively suppress transient receptor potential ankyrin 1 activity, but not transient receptor potential vanilloid 1 activity.
Miyano K; Minami K; Yokoyama T; Ohbuchi K; Yamaguchi T; Murakami S; Shiraishi S; Yamamoto M; Matoba M; Uezono Y
Anesth Analg; 2015 Apr; 120(4):790-8. PubMed ID: 25642661
[TBL] [Abstract][Full Text] [Related]
6. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?
Knotkova H; Pappagallo M; Szallasi A
Clin J Pain; 2008 Feb; 24(2):142-54. PubMed ID: 18209521
[TBL] [Abstract][Full Text] [Related]
7. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
[TBL] [Abstract][Full Text] [Related]
8. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanol.
Vetter I; Wyse BD; Roberts-Thomson SJ; Monteith GR; Cabot PJ
Eur J Pain; 2008 May; 12(4):441-54. PubMed ID: 17826200
[TBL] [Abstract][Full Text] [Related]
10. [3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.
Bianchi BR; El Kouhen R; Neelands TR; Lee CH; Gomtsyan A; Raja SN; Vaidyanathan SN; Surber B; McDonald HA; Surowy CS; Faltynek CR; Moreland RB; Jarvis MF; Puttfarcken PS
J Pharmacol Exp Ther; 2007 Oct; 323(1):285-93. PubMed ID: 17660385
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning, functional characterization of the porcine transient receptor potential V1 (pTRPV1) and pharmacological comparison with endogenous pTRPV1.
Ohta T; Komatsu R; Imagawa T; Otsuguro K; Ito S
Biochem Pharmacol; 2005 Dec; 71(1-2):173-87. PubMed ID: 16288992
[TBL] [Abstract][Full Text] [Related]
12. Hydroxy-alpha-sanshool activates TRPV1 and TRPA1 in sensory neurons.
Koo JY; Jang Y; Cho H; Lee CH; Jang KH; Chang YH; Shin J; Oh U
Eur J Neurosci; 2007 Sep; 26(5):1139-47. PubMed ID: 17767493
[TBL] [Abstract][Full Text] [Related]
13. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
[TBL] [Abstract][Full Text] [Related]
14. Contribution of transient receptor potential vanilloid subtype 1 to the analgesic and antihyperalgesic activity of nefopam in rodents.
Verleye M; Gillardin JM
Pharmacology; 2009; 83(2):116-21. PubMed ID: 19096234
[TBL] [Abstract][Full Text] [Related]
15. Proton conductance of human transient receptor potential-vanilloid type-1 expressed in oocytes of Xenopus laevis and in Chinese hamster ovary cells.
Vulcu SD; Liewald JF; Gillen C; Rupp J; Nawrath H
Neuroscience; 2004; 125(4):861-6. PubMed ID: 15120847
[TBL] [Abstract][Full Text] [Related]
16. Functional changes in the vanilloid receptor subtype 1 channel during and after acute desensitization.
Novakova-Tousova K; Vyklicky L; Susankova K; Benedikt J; Samad A; Teisinger J; Vlachova V
Neuroscience; 2007 Oct; 149(1):144-54. PubMed ID: 17869438
[TBL] [Abstract][Full Text] [Related]
17. A novel role for the TRPV1 channel in UV-induced matrix metalloproteinase (MMP)-1 expression in HaCaT cells.
Lee YM; Kim YK; Kim KH; Park SJ; Kim SJ; Chung JH
J Cell Physiol; 2009 Jun; 219(3):766-75. PubMed ID: 19206161
[TBL] [Abstract][Full Text] [Related]
18. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord.
Zhou HY; Chen SR; Chen H; Pan HL
J Pharmacol Exp Ther; 2008 Nov; 327(2):375-82. PubMed ID: 18669865
[TBL] [Abstract][Full Text] [Related]
19. Transient receptor potential vanilloid type 1 receptor regulates glutamatergic synaptic inputs to the spinothalamic tract neurons of the spinal cord deep dorsal horn.
Kim H; Cui L; Kim J; Kim SJ
Neuroscience; 2009 May; 160(2):508-16. PubMed ID: 19236908
[TBL] [Abstract][Full Text] [Related]
20. Ethanol dilates coronary arteries and increases coronary flow via transient receptor potential vanilloid 1 and calcitonin gene-related peptide.
Gazzieri D; Trevisani M; Tarantini F; Bechi P; Masotti G; Gensini GF; Castellani S; Marchionni N; Geppetti P; Harrison S
Cardiovasc Res; 2006 Jun; 70(3):589-99. PubMed ID: 16579978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
